132 related articles for article (PubMed ID: 11023935)
21. Double-blind comparison of perindopril and captopril in hypertension. Effects on left ventricular morphology and function.
Grandi AM; Venco A; Barzizza F; Petrucci E; Scalise F; Perani G; Marchesi E; Folino P; Finardi G
Am J Hypertens; 1991 Jun; 4(6):516-20. PubMed ID: 1873003
[TBL] [Abstract][Full Text] [Related]
22. Long-term effects of perindopril on metabolic parameters and the heart in the spontaneously hypertensive/NIH-corpulent rat with non-insulin-dependent diabetes mellitus and hypertension.
Striffler JS; Bhathena SJ; Michaelis OE; Campbell JD; Hansen CT; Scalbert E; Thibault N; Velasquez MT
Metabolism; 1998 Oct; 47(10):1199-204. PubMed ID: 9781621
[TBL] [Abstract][Full Text] [Related]
23. Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance.
Quilliot D; Alla F; Böhme P; Bruntz JF; Hammadi M; Dousset B; Ziegler O; Zannad F
Int J Obes (Lond); 2005 Nov; 29(11):1321-8. PubMed ID: 16116494
[TBL] [Abstract][Full Text] [Related]
24. Left ventricular end-diastolic dimensions measured at the P wave and Q wave during a randomized, double-blind one-year follow-up study comparing the effect of atenolol vs. hydrochlorothiazide + amiloride on blood pressure in men with mild to moderate hypertension.
Otterstad JE; Froeland G; Erikssen J
Scand J Clin Lab Invest; 1993 Apr; 53(2):155-62. PubMed ID: 8469914
[TBL] [Abstract][Full Text] [Related]
25. Insulin and diastolic dysfunction in lean and obese hypertensives: genetic influence.
Grandi AM; Zanzi P; Fachinetti A; Gaudio G; Ceriani L; Bertolini A; Guasti L; Venco A
Hypertension; 1999 Dec; 34(6):1208-14. PubMed ID: 10601120
[TBL] [Abstract][Full Text] [Related]
26. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
[TBL] [Abstract][Full Text] [Related]
27. Treatment of hypertension with perindopril reduces plasma atrial natriuretic peptide levels, left ventricular mass, and improves echocardiographic parameters of diastolic function.
Yalçin F; Aksoy FG; Muderrisoglu H; Sabah I; Garcia MJ; Thomas JD
Clin Cardiol; 2000 Jun; 23(6):437-41. PubMed ID: 10875035
[TBL] [Abstract][Full Text] [Related]
28. [Arterial stiffness, wave reflections and myocardial protection: the REASON project].
London GM
Drugs; 2003; 63 Spec No 1():9-17. PubMed ID: 12708879
[TBL] [Abstract][Full Text] [Related]
29. Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity.
Iacobellis G; Ribaudo MC; Zappaterreno A; Vecci E; Tiberti C; Di Mario U; Leonetti F
Obes Res; 2003 Apr; 11(4):518-24. PubMed ID: 12690080
[TBL] [Abstract][Full Text] [Related]
30. Insulin resistance and hyperinsulinemia: No independent relation to left ventricular mass in humans.
Galvan AQ; Galetta F; Natali A; Muscelli E; Sironi AM; Cini G; Camastra S; Ferrannini E
Circulation; 2000 Oct; 102(18):2233-8. PubMed ID: 11056098
[TBL] [Abstract][Full Text] [Related]
31. Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass.
Licata G; Scaglione R; Corrao S; Ganguzza A; Mazzola G; Arnone S; Dichiara MA; Licata A; Merlino G; Di Chiara T
J Hypertens; 1995 Jun; 13(6):611-8. PubMed ID: 7594417
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.
Pollare T; Lithell H; Selinus I; Berne C
BMJ; 1989 Apr; 298(6681):1152-7. PubMed ID: 2500169
[TBL] [Abstract][Full Text] [Related]
33. Assessment of antihypertensive efficacy of perindopril: results of double-blind multicenter studies versus reference drugs.
Thurston H; Desche P
J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S45-9. PubMed ID: 1725202
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats.
Toblli JE; DeRosa G; Rivas C; Cao G; Piorno P; Pagano P; Forcada P
J Hypertens; 2003 Mar; 21(3):611-20. PubMed ID: 12640256
[TBL] [Abstract][Full Text] [Related]
35. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
Hakamäki T; Lehtonen A
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients.
Cholley BP; Shroff SG; Sandelski J; Korcarz C; Balasia BA; Jain S; Berger DS; Murphy MB; Marcus RH; Lang RM
Circulation; 1995 Feb; 91(4):1052-62. PubMed ID: 7850941
[TBL] [Abstract][Full Text] [Related]
37. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.
Sihm I; Schroeder AP; Aalkjaer C; Mulvany MJ; Thygesen K; Lederballe O
Am J Hypertens; 1998 Mar; 11(3 Pt 1):263-71. PubMed ID: 9544865
[TBL] [Abstract][Full Text] [Related]
38. How can we block sympathetic overactivity? Effects of rilmenidine and atenolol in overweight hypertensive patients.
Konrady AO; Kasherininov YR; Shavarov AA; Shavarova EK; Vachrameeva NV; Krutikov AN; Smirnova EV; Shlyakhto EV
J Hum Hypertens; 2006 Jun; 20(6):398-406. PubMed ID: 16543910
[TBL] [Abstract][Full Text] [Related]
39. Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA).
Malmqvist K; Kahan T; Edner M; Bergfeldt L
Am J Cardiol; 2002 Nov; 90(10):1107-12. PubMed ID: 12423712
[TBL] [Abstract][Full Text] [Related]
40. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.
London GM; Pannier B; Guerin AP; Marchais SJ; Safar ME; Cuche JL
Circulation; 1994 Dec; 90(6):2786-96. PubMed ID: 7994822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
